Zentalis Pharmaceuticals, Inc. Operating Margin in % from Q1 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2024 to Q3 2025.
  • Zentalis Pharmaceuticals, Inc. Operating Margin for the quarter ending September 30, 2025 was -615 %, a 19.2% decline year-over-year.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)

Zentalis Pharmaceuticals, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -615 -99.2 -19.2% Jul 1, 2025 Sep 30, 2025
Q2 2025 -681 -137 -25.2% Apr 1, 2025 Jun 30, 2025
Q1 2025 -789 -150 -23.5% Jan 1, 2025 Mar 31, 2025
Q4 2024 -284 Oct 1, 2024 Dec 31, 2024
Q3 2024 -516 Jul 1, 2024 Sep 30, 2024
Q2 2024 -544 Apr 1, 2024 Jun 30, 2024
Q1 2024 -639 Jan 1, 2024 Mar 31, 2024

Zentalis Pharmaceuticals, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -284 Jan 1, 2024 Dec 31, 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.